Investigators highlighted an association between treatment retention over time and the out-of-pocket cost for patients with hepatic encephalopathy taking rifaximin.
A pair of studies presented at EULAR 2023 offer perspective on the potential for postpartum depression as well as symptoms of depression and anxiety during pregnancy among women with rheumatic disease.
Using data from over 16 million people in the United States, Angela Y Chang and colleagues explore how multimorbidity, when considering 63 different conditions, influences health care expenditure.